Startup 302 is Delaware's premier funding competition for technology and technology-enabled startups led by underrepresented founders.
Entrepreneurs from across the U.S. will compete for non-dilutive funding, access to mentors, and valuable connections.
You could win up to $75,000 and learn from business leaders and influencers.
Entrepreneurs from across the United States can compete for funding, access to mentors and valuable connections. Be part of Delaware’s premier funding competition for tech-focused startups led by underrepresented founders.
Who is eligible?
For early-stage innovators who have generated less than $10,000 in annual revenue and have raised less than $50k in funding (including dilutive and nondilutive sources).
For innovations across sectors, with a focus on fintech, automation, big data, health tech, SaaS and e-commerce innovations for financial services.
For startups in therapeutics, pharmaceuticals, diagnostics, nutrition, industrial biotechnology, agriculture biotechnology and other life sciences.
For startups in cleantech, chemical ingredients from naturally derived sources and ocean-safe products that focus on environmental impact.
For startups that reside in Delaware that are tech-enabled. Tech-enabled companies aren't building the internet, mobile devices or social media platforms; they're using those technologies.
There are additional cash awards for startups aligned with the following criteria: University of Delaware Alumni, Grad Students or Faculty; Primary Operations in the State of Delaware.
Contact ecrell @ choosdelaware.com
“Delaware ecosystem [is] helpful in providing a variety of resources, including people, time, space, and funding, to new entrepreneurs. Many of the events, workshops, and communities under the ecosystem umbrella were helpful to us, especially at the beginning of Carbon Reform’s formation, in providing context and access to the world we were getting into. There are many seasoned entrepreneurs, investors, and industry leaders involved who are generously willing to share their time and input, which we have taken advantage of since our start.” - Jo Norris, CoFounder, Carbon Reform
I “founded BioCurie in Delaware because of Delaware’s business-friendly environment and proximity to biopharma companies. This makes it an ideal place for innovative businesses to thrive. We have NIIMBL here and North of us in Philadelphia, we have ‘Cellicon Valley’ and the Greater Philadelphia region with all the cell and gene therapy companies. We’ve got all the big pharma just north in New Jersey. The contract manufacturers in cell and gene therapy are in Maryland. We also collaborate with the University of Delaware through one of its grant programs.” - Irene Romdel, Founder and CEO, BioCurie
"Besides the financial award, winning gave me reassurance that the problem I'm working on solving is valuable. I really do appreciate Startup 302 for helping underrepresented founders like myself with funding and resources to grow our companies. " - Kasai Guthrie, CEO, Neggster
"The Delaware support for entrepreneurs has been critical in our ability to move this technology forward. The Startup 302 grant will enable us to deliver a much-needed advancement to the market for Parkinson’s patients.” -Theresa Litherland, cofounder and president, Resonate Forward
New This Year. The finals will be held in person in Wilmington, DE.
More to come.
Finalists will be required to attend.
Be a sponsor. Contact us today at nolson @ choosedelaware.com.
Copyright © 2023 DPP - All Rights Reserved.